SearchDictionaryMobileLogin

David H Henry Selected Research

Anemia

05/2007Increased importance of intravenous iron in chemotherapy-induced anemia.
01/2007Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfection.
01/2007Epoetin alfa treatment for patients with chemotherapy-induced anemia.
07/2006The role of intravenous iron in cancer-related anemia.
07/2006Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia.
06/2006Clinical benefits and risks associated with epoetin and darbepoetin in patients with chemotherapy-induced anemia: a systematic review of the literature.
10/2004Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future.

Articles by Research Topic

Disease

7Anemia
05/2007 - 10/2004
4Neoplasms (Cancer)
02/2007 - 01/2004
1Thrombosis (Thrombus)
05/2008
1Kaposi Sarcoma (Kaposi's Sarcoma)
03/2008
1Acquired Immunodeficiency Syndrome (AIDS)
03/2008
1Small Cell Carcinoma
12/2005
1Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2004

Drug/Important Bio-Agent (IBA)

7Epoetin Alfa (Epogen)FDA Link
02/2007 - 01/2004
4IronIBA
05/2008 - 07/2006
1N-((2S)-2-mercapto-1-oxo-4-(3,4,4- trimethyl- 2,5- dioxo- 1- imidazolidinyl)butyl)- L- leucyl- N,3- dimethyl-L-ValinamideIBA
03/2008
1ferric gluconate (Ferrlecit)FDA Link
02/2007
1InterferonsIBA
01/2007
1Ribavirin (Virazole)FDA LinkGeneric
01/2007
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2004
1Etoposide (VP 16)FDA LinkGeneric
04/2004
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2004

Therapy/Procedure

6Drug Therapy (Chemotherapy)
05/2007 - 02/2005